
May 23rd, 2012 | By: Mark Hall | Comments
A new class of anti-cancer drugs is nearing the clinical trial phase and may eventually be available for treatment of aggressive diseases like pancreatic cancer, and potentially mesothelioma.
Developed by researchers at the University of Sydney, these cancer-fighting drugs manage the spread and growth of cancerous cells, with minimal side effects.
Mesothelioma is a rare disease that




Mesothelioma Lawsuit Reveals Rare Case of Sho...
Asbestos Awareness Group Details 2012 Asbesto...
Report: Cancer Deaths and Lung Cancer Deaths ...
ADAO Will Honor Mesothelioma Victim Steve McQ...




